Revenue: The sum of all revenue fields included for a company's operating activities.
Abbott Laboratories (ABT) had Revenue of $10.36B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$10.36B |
$1.32B |
|
$4.47B |
|
$5.89B |
|
$8.66B |
|
$1.69B |
|
$85.00M |
|
$1.78B |
|
$1.78B |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
$1.69B |
|
$2.45B |
|
1.74B |
|
1.75B |
|
$0.76 |
|
$0.76 |
|
| Balance Sheet Financials | |
$23.15B |
|
$10.93B |
|
$58.30B |
|
$81.45B |
|
$13.00B |
|
$12.74B |
|
$19.38B |
|
$32.38B |
|
$49.06B |
|
$19.44B |
|
$49.06B |
|
1.74B |
|
| Cash Flow Statement Financials | |
$1.42B |
|
$-470.00M |
|
$-2.06B |
|
$7.62B |
|
$6.53B |
|
$-1.08B |
|
$289.00M |
|
$-1.03B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
0.21 |
|
0.27 |
|
56.86% |
|
16.34% |
|
16.34% |
|
-- |
|
17.17% |
|
12.79% |
|
$933.00M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.67 |
|
1.41 |
|
63.66 |
|
2.70% |
|
6.81% |
|
1.63% |
|
2.14% |
|
$28.20 |
|
$0.53 |
|
$0.81 |
|